PACS Group (NYSE:PACS) Stock Gets Price Target Increase from Stephens

PACS Group (NYSE:PACS) had its price target boosted by stock analysts at Stephens from $60.00 to $64.00 in a report issued on Thursday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Stephens‘s price objective would indicate a potential upside of 26.38% from the stock’s previous close.

Several other research firms have also recently weighed in on PACS. Truist Financial set a $62.00 price objective on PACS Group in a research report on Wednesday, September 2nd. Zacks Research downgraded shares of PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Royal Bank Of Canada boosted their target price on shares of PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research note on Thursday, August 6th. Weiss Ratings raised shares of PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Finally, Wall Street Zen downgraded shares of PACS Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 8th. Six research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, PACS Group has an average rating of “Moderate Buy” and a consensus price target of $59.67.

PACS Group Stock Up 0.8%

Shares of NYSE PACS opened at $50.64 on Thursday. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.91 and a quick ratio of 0.91. The company has a 50-day moving average price of $44.42 and a 200-day moving average price of $39.91. The stock has a market capitalization of $8.02 billion, a P/E ratio of 28.53, a P/E/G ratio of 1.46 and a beta of -0.14. PACS Group has a 1 year low of $10.31 and a 1 year high of $51.68.

PACS Group (NYSE:PACS) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.58 by $0.05. The business had revenue of $1.50 billion for the quarter, compared to analysts’ expectations of $1.46 billion. PACS Group had a return on equity of 33.39% and a net margin of 4.87%. On average, equities research analysts forecast that PACS Group will post 2.13 EPS for the current fiscal year.

Insider Activity at PACS Group

In other PACS Group news, CEO Jason Murray sold 167,434 shares of the stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $50.24, for a total transaction of $8,411,884.16. Following the sale, the chief executive officer owned 53,954,101 shares in the company, valued at $2,710,654,034.24. This represents a 0.31% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mark Hancock sold 186,696 shares of the firm’s stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $50.45, for a total value of $9,418,813.20. Following the completion of the transaction, the director directly owned 53,318,884 shares of the company’s stock, valued at $2,689,937,697.80. The trade was a 0.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 1,762,431 shares of company stock valued at $80,686,053. 70.10% of the stock is owned by insiders.

Institutional Trading of PACS Group

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Dimensional Fund Advisors LP raised its position in shares of PACS Group by 370.2% in the first quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock worth $25,051,000 after buying an additional 614,250 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in PACS Group during the second quarter valued at $8,196,000. Principal Financial Group Inc. purchased a new position in PACS Group during the first quarter worth about $3,171,000. Arrowstreet Capital Limited Partnership increased its stake in PACS Group by 44.6% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock worth $9,274,000 after acquiring an additional 89,067 shares during the last quarter. Finally, Cantor Fitzgerald Investment Advisors L.P. purchased a new stake in shares of PACS Group in the 3rd quarter valued at about $1,920,000.

Key PACS Group News

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: PACS delivered a strong third quarter: earnings were $0.63 per share versus estimates of $0.56–$0.58, and revenue of $1.50 billion topped the $1.46 billion consensus. Adjusted EBITDA rose 33.6%, with the article attributing growth to maturing nursing facilities. PACS Group Q3 2026 earnings
• Positive Sentiment: The company raised its 2026 outlook to $5.95–$6.05 billion in revenue and $685–$695 million in adjusted EBITDA. The upgraded forecast supports expectations for continued operating growth. PACS raises 2026 outlook
• Positive Sentiment: PACS leaders highlighted acquisitions in Florida and Texas and occupancy near 90%, signaling expansion and healthy facility demand. An aging population and limited new senior-housing construction may also support the sector’s long-term demand backdrop. PACS acquisitions and occupancy
• Negative Sentiment: CEO Jason Murray, director Mark Hancock, and CAO Michelle Lewis disclosed stock sales. The transactions were made under pre-arranged Rule 10b5-1 plans, and the executives retained substantial holdings, which may limit the signal’s significance. PACS insider sales

PACS Group Company Profile

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.